Strata Skin Sciences, Inc. (SSKN) Financial Statements (2023 and earlier)
Company Profile
Business Address |
5 WALNUT GROVE DRIVE HORSHAM, PA 19044 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 12,586 | 10,604 | 8,129 | 16,487 | 4,069 | 3,928 | 3,303 | ||
Cash and cash equivalents | 12,586 | 10,604 | 8,129 | 16,487 | 4,069 | 3,928 | 3,303 | ||
Restricted cash and investments | 7,508 | 7,500 | 15 | ||||||
Receivables | 3,433 | 2,944 | 4,386 | 3,393 | 3,141 | 3,390 | 4,068 | ||
Inventory, net of allowances, customer advances and progress billings | 3,489 | 3,444 | 3,027 | 2,794 | 3,009 | 2,817 | 4,128 | ||
Inventory | 3,489 | 3,444 | 3,027 | 2,794 | 3,009 | 2,817 | 4,128 | ||
Other undisclosed current assets | 462 | 331 | 513 | 536 | 533 | 617 | 465 | ||
Total current assets: | 19,970 | 24,831 | 23,555 | 23,210 | 10,752 | 10,752 | 11,979 | ||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 638 | 988 | 1,314 | ✕ | ✕ | ✕ | ✕ | ||
Property, plant and equipment | 6,883 | 5,529 | 5,369 | 5,301 | 7,703 | 10,180 | 13,851 | ||
Intangible assets, net (including goodwill) | 18,886 | 15,148 | 16,758 | 18,568 | 20,128 | 22,215 | 24,155 | ||
Goodwill | 8,803 | 8,803 | 8,803 | 8,803 | 8,803 | 8,803 | 8,928 | ||
Intangible assets, net (excluding goodwill) | 10,083 | 6,345 | 7,955 | 9,765 | 11,325 | 13,412 | 15,227 | ||
Deferred costs | 1,293 | ||||||||
Other noncurrent assets | 216 | 282 | 347 | 428 | 48 | 46 | 94 | ||
Total noncurrent assets: | 26,623 | 21,947 | 23,788 | 24,297 | 27,879 | 32,441 | 39,393 | ||
TOTAL ASSETS: | 46,593 | 46,778 | 47,343 | 47,507 | 38,631 | 43,193 | 51,372 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 9,199 | 7,454 | 7,014 | 6,264 | 4,637 | 3,845 | 6,607 | ||
Accounts payable | 2,822 | 2,764 | 1,880 | 1,764 | 2,277 | 1,853 | 4,446 | ||
Accrued liabilities | 6,377 | 4,690 | 5,134 | 4,500 | 2,360 | 1,992 | 2,161 | ||
Deferred revenue | 3,285 | 2,262 | 2,832 | 2,099 | ✕ | ✕ | ✕ | ||
Debt | 8,753 | 313 | 252 | 2,387 | 1,714 | ||||
Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 291 | 235 | 173 | ||
Other undisclosed current liabilities | 318 | 369 | 7,275 | 357 | 339 | 299 | |||
Total current liabilities: | 12,802 | 18,838 | 17,434 | 8,615 | 7,672 | 6,133 | 7,079 | ||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 7,711 | 1,760 | 1,078 | 7,145 | 7,853 | 9,752 | 10,179 | ||
Long-term debt, excluding current maturities | 7,319 | 1,050 | 7,145 | 7,853 | 9,752 | 10,179 | |||
Operating lease, liability | 392 | 710 | 1,078 | ✕ | ✕ | ✕ | ✕ | ||
Liabilities, other than long-term debt | 300 | 288 | 178 | 388 | 861 | 574 | 7,281 | ||
Accounts payable and accrued liabilities | 20 | 13 | 58 | ||||||
Deferred revenue | 14 | ✕ | ✕ | ✕ | ✕ | ||||
Deferred tax liabilities, net | ✕ | ✕ | ✕ | 414 | 359 | 119 | |||
Deferred income tax liabilities | 266 | 254 | ✕ | ✕ | ✕ | ✕ | |||
Other liabilities | 34 | 178 | 388 | 444 | 97 | 62 | |||
Derivative instruments and hedges, liabilities | 3 | 105 | 7,042 | ||||||
Other undisclosed noncurrent liabilities | 366 | 111 | 12,015 | 10,746 | |||||
Total noncurrent liabilities: | 8,377 | 2,048 | 1,256 | 7,644 | 8,714 | 22,341 | 28,206 | ||
Total liabilities: | 21,179 | 20,886 | 18,690 | 16,259 | 16,386 | 28,474 | 35,285 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent, including: | 25,414 | 25,892 | 28,653 | 31,248 | 22,245 | 14,719 | 16,087 | ||
Preferred stock | 1 | 1 | |||||||
Common stock | 34 | 34 | 33 | 30 | 4 | 11 | 10 | ||
Additional paid in capital | 247,059 | 244,831 | 243,180 | 241,988 | 251,643 | 225,280 | 223,315 | ||
Accumulated other comprehensive income | 2 | 1 | |||||||
Accumulated deficit | (221,679) | (218,973) | (214,561) | (210,771) | (229,406) | (210,575) | (207,240) | ||
Other undisclosed stockholders' equity attributable to parent | 1 | 1 | 4 | ||||||
Total stockholders' equity: | 25,414 | 25,892 | 28,653 | 31,248 | 22,245 | 14,719 | 16,087 | ||
TOTAL LIABILITIES AND EQUITY: | 46,593 | 46,778 | 47,343 | 47,507 | 38,631 | 43,193 | 51,372 |
Income Statement (P&L) ($ in thousands) Annual | Quarterly
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 29,977 | 23,090 | 31,586 | 29,855 | 31,449 | 31,757 | 18,495 | |
Revenue, net | ✕ | ✕ | ✕ | ✕ | 31,449 | 31,757 | 18,495 | |
Cost of revenue | (10,127) | (8,956) | (11,316) | (12,735) | (13,498) | (12,636) | (13,719) | |
Cost of goods and services sold | (4,818) | |||||||
Gross profit: | 19,850 | 14,134 | 20,270 | 17,120 | 17,951 | 19,121 | 4,776 | |
Operating expenses | (24,252) | (18,210) | (23,280) | (20,475) | (20,361) | (22,718) | (21,251) | |
Operating loss: | (4,402) | (4,076) | (3,010) | (3,355) | (2,410) | (3,597) | (16,475) | |
Nonoperating income (expense) | 1,730 | (61) | (929) | (942) | (16,292) | 21 | 33 | |
Other nonoperating income | 200 | 17 | 21 | 33 | ||||
Interest and debt expense | 2,029 | (414) | (1,142) | (11,799) | (4,900) | (10,200) | ||
Other undisclosed income from continuing operations before equity method investments, income taxes | 414 | 1,142 | 11,799 | 5,396 | 1,814 | |||
Loss from continuing operations before equity method investments, income taxes: | (643) | (4,137) | (3,939) | (4,297) | (18,702) | (3,080) | (24,828) | |
Other undisclosed loss from continuing operations before income taxes | (2,029) | |||||||
Loss from continuing operations before income taxes: | (2,672) | (4,137) | (3,939) | (4,297) | (18,702) | (3,080) | (24,828) | |
Income tax expense (benefit) | (34) | (275) | 149 | 264 | (129) | (255) | (119) | |
Net loss attributable to parent: | (2,706) | (4,412) | (3,790) | (4,033) | (18,831) | (3,335) | (24,947) | |
Preferred stock dividends and other adjustments | (2,962) | |||||||
Other undisclosed net income available to common stockholders, basic | 193 | 1,124 | ||||||
Net loss available to common stockholders, basic: | (2,706) | (4,412) | (3,597) | (2,909) | (18,831) | (3,335) | (27,909) | |
Interest on convertible debt | 3,117 | |||||||
Other undisclosed net loss available to common stockholders, diluted | (5,396) | |||||||
Net loss available to common stockholders, diluted: | (2,706) | (4,412) | (3,597) | (2,909) | (15,714) | (8,731) | (27,909) |
Comprehensive Income ($ in thousands)Annual | Quarterly
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (2,706) | (4,412) | (3,790) | (4,033) | (18,831) | (3,335) | (24,947) | |
Comprehensive loss: | (2,706) | (4,412) | (3,790) | (4,033) | (18,831) | (3,335) | (24,947) | |
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (2) | 1 | (2,961) | |||||
Comprehensive loss, net of tax, attributable to parent: | (2,706) | (4,412) | (3,790) | (4,033) | (18,833) | (3,334) | (27,908) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.